pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures

By Douglas E. V. Pires, Tom L. Blundell, David B. Ascher. Journal of Medicinal Chemistry, 2015

4,911 citations recorded by the source corpus.

Drug development has a high attrition rate, with poor pharmacokinetic and safety properties a significant hurdle. Computational approaches may help minimize these risks. We have developed a novel approach (pkCSM) which uses graph-based signatures to develop predictive models of central ADMET properties for drug development. pkCSM performs as well or better than current methods. A freely accessible web server (http://structure.bioc.cam.ac.uk/pkcsm), which retains no information submitted to it, provides an integrated platform to rapidly evaluate pharmacokinetic and toxicity properties.

Subfields: Computational Theory and Mathematics, Materials Chemistry, Organic Chemistry

View Paper: https://www.semanticscholar.org/paper/3a01d62b9e180ee3d2dfdec3910a60aead2de1f9

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Computational Theory and Mathematics

  1. Antoine Daina
  2. Vincent Zoete
  3. Olivier Michielin
  4. Carlos H. M. Rodrigues
  5. Douglas E. V. Pires
  6. David B. Ascher
  7. Yoochan Myung
  8. Xianhuan Shen

In Materials Chemistry

  1. Antoine Daina
  2. Vincent Zoete
  3. Olivier Michielin
  4. Douglas E. V. Pires
  5. Carlos H. M. Rodrigues
  6. David B. Ascher
  7. Yoochan Myung
  8. Dongsheng Cao

In Organic Chemistry

  1. Carlos H. M. Rodrigues
  2. Vincent Zoete
  3. Olivier Michielin
  4. Antoine Daina
  5. Douglas E. V. Pires
  6. David B. Ascher

Citations in the corpus